Bessemer Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-160
| Closed | -$6K | – | 2096 |
|
2022
Q1 | $6K | Hold |
160
| – | – | ﹤0.01% | 1495 |
|
2021
Q4 | $5K | Hold |
160
| – | – | ﹤0.01% | 1611 |
|
2021
Q3 | $4K | Hold |
160
| – | – | ﹤0.01% | 1561 |
|
2021
Q2 | $6K | Hold |
160
| – | – | ﹤0.01% | 1420 |
|
2021
Q1 | $7K | Sell |
160
-340
| -68% | -$14.9K | ﹤0.01% | 1364 |
|
2020
Q4 | $22K | Sell |
500
-150
| -23% | -$6.6K | ﹤0.01% | 1164 |
|
2020
Q3 | $36K | Sell |
650
-350
| -35% | -$19.4K | ﹤0.01% | 971 |
|
2020
Q2 | $63K | Buy |
+1,000
| New | +$63K | ﹤0.01% | 1316 |
|
2017
Q4 | – | Sell |
-50,009
| Closed | -$1.55M | – | 1855 |
|
2017
Q3 | $1.55M | Hold |
50,009
| – | – | 0.01% | 520 |
|
2017
Q2 | $1.37M | Buy |
+50,009
| New | +$1.37M | 0.01% | 575 |
|
2017
Q1 | – | Sell |
-23,160
| Closed | -$335K | – | 1956 |
|
2016
Q4 | $335K | Buy |
+23,160
| New | +$335K | ﹤0.01% | 981 |
|